Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THN102 versus modafinil for residual daytime sleepiness in narcolepsy
2015-005035-41Phase 2Completed
- Sponsor
- Theranexus
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of THN102, modafinil and flecainide in narcolepsy (2 arms), sponsored by Theranexus. Primary endpoint: Mean Epworth Sleepiness Scale total score. Started Apr 2018; status: completed.
02
Drugs
THN102modafinilflecainide
03
Conditions
narcolepsy
Beyond the preview
Go deeper on 2015-005035-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005035-41.